Skip to content
healthcare.dev

Aphexda

NDC 82737-073, Motixafortide, injection, powder, lyophilized, for solution, from BioLineRx USA Inc.

Product NDC
82737-073
Status
Listed
Labeler
BioLineRx USA Inc
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA217159
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/82737-073 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • MOTIXAFORTIDE ACETATE62 mg/1.7mL
Package NDCNDC-11Package
82737-073-01827370073011 VIAL, GLASS in 1 CARTON (82737-073-01) / 1.7 mL in 1 VIAL, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/f7cdc584-ebf0-a68e-e053-6294a90a9ea9
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=82737-073

Use it

Look up 82737-073 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/82737-073 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 82737-073. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.